Evidence Dose
← All articles Supplements

Creatine Monohydrate vs 5 Other Forms: What Science Shows

Dr Cath
Chemistry PhD · evidence-based supplementation
Creatine Monohydrate vs 5 Other Forms: What Science Shows

Which creatine form should you actually buy?

Creatine monohydrate, unless you have a specific reason that has nothing to do with performance. Every alternative on the shelf is sold on the same premise — better solubility, better absorption, better stability, less bloating — and that premise is a chemistry argument, not an outcome argument. The compound that carries the research is monohydrate. The alternatives carry the marketing.

That is not a reflexive dismissal. Some of the chemistry behind the alternative forms is real and measurable. The problem is what happens between the chemistry and the muscle, and that is where the comparative human data thins out to almost nothing.

What is creatine monohydrate, and what is it not?

Creatine is a nitrogen-containing organic acid the body also makes endogenously and obtains from the diet. Creatine monohydrate is creatine crystallised with one molecule of water per molecule of creatine — the water is part of the crystal lattice, not an additive. Once it dissolves, the molecule delivered to your bloodstream is identical to the molecule delivered by any other creatine form. Nothing in a hydrochloride, ester, malate or nitrate changes the active species; they change how it is packaged before dissolution.

Also known as: creatine mono, Cr monohydrate.

Not to be confused with: creatinine — the cyclised breakdown product of creatine, measured clinically as a marker of kidney filtration. Creatine and creatinine differ by one water molecule and one enormous difference in what they do. Any creatine form that degrades in the bottle or the stomach is degrading toward creatinine, which is inert as a supplement.

What is monohydrate genuinely good for?

Two things are worth separating.

First, the evidence base itself. Almost the entire human literature on creatine supplementation — resistance training, repeated high-intensity effort, muscle creatine loading, long-term tolerability — was generated using monohydrate. When someone says "creatine is well studied", they are describing monohydrate specifically. That is an established statement about the research record, and it is the single most important fact in this comparison.

Second, cost and availability. Monohydrate is the cheapest form per gram of actual creatine and the most widely produced. A more expensive form has to earn that premium against a comparator that is both better evidenced and less costly.

What are the real drawbacks of monohydrate?

They exist, and they are worth stating plainly rather than dismissing.

  • Solubility. Monohydrate dissolves slowly in cold water and often leaves grit at the bottom of a glass. This is straightforward physical chemistry, not a controversy. Undissolved powder in the glass is powder you did not swallow.
  • Gastrointestinal complaints. Some people report bloating or an osmotic effect, most commonly with large single doses taken during a rapid loading phase. Splitting the daily amount across the day is the conventional response, and it is a reasonable one on osmotic grounds.
  • Water retention. Creatine is osmotically active inside muscle cells, so intracellular water increases. For most people this is irrelevant or desirable; for anyone in a weight-class sport it is a genuine consideration.
  • Purity variability. Creatine production can leave trace impurities, including creatinine and other by-products. This is a manufacturing-quality issue rather than a property of the molecule.

Notice that every one of these is a formulation or dosing problem. None of them is a claim that monohydrate fails to raise muscle creatine.

How does creatine work, and what would a better form have to improve?

Mechanistically, creatine is phosphorylated in muscle to phosphocreatine, which acts as a rapid phosphate donor for regenerating ATP during short, intense effort. The functional target of supplementation is therefore intramuscular creatine content — you are trying to move a storage pool, not maintain a plasma concentration.

That framing matters, because it defines the ceiling for any improved form. Oral creatine monohydrate is described in the pharmacokinetic literature as well absorbed from the gut; the rate-limiting step for muscle loading is transport into the muscle cell via the creatine transporter, and that transporter saturates. A form that dissolves faster, or that produces a higher transient plasma peak, is optimising a step that was not the bottleneck.

So the marketing logic — more soluble, therefore more absorbed, therefore more effective — chains three levels of the evidence hierarchy together as if each one guaranteed the next. Solubility is measurable chemistry. Absorption is an exposure question. Muscle loading is an intermediate outcome. Strength or power is the clinically meaningful outcome. Establishing the first does not establish the last.

What about the five alternative forms?

Creatine hydrochloride (creatine HCl)

Creatine bound to hydrochloric acid, forming a salt that is markedly more soluble in water than monohydrate. The solubility difference is real and easily demonstrated in a glass — that part is established chemistry. The claim that this translates into greater muscle creatine loading or better training outcomes is unknown: it would require a direct head-to-head human comparison against monohydrate at matched creatine doses, and I am not aware of published work that settles it. Higher solubility is also used to justify smaller serving sizes, which is a marketing inference from solubility, not a demonstrated equivalence of dose.

Creatine ethyl ester

An esterified creatine, originally promoted on the mechanistic argument that the ester improves membrane permeability. The chemistry works against it: creatine esters are prone to cyclisation to creatinine, and acidic conditions accelerate that conversion. A molecule that converts to creatinine before absorption is delivering the wrong compound. On the available comparative data this form performs worse than monohydrate rather than better, and I would not pay a premium for it.

Buffered creatine

Creatine formulated at an elevated pH, marketed on the argument that it resists conversion to creatinine in the stomach and therefore requires less material. The stability premise addresses a problem that is smaller than the marketing implies — monohydrate's conversion to creatinine during normal gastric transit is limited. Whether buffering improves any outcome relative to monohydrate is unknown in the sense that matters: the specific comparison has not been convincingly resolved in humans.

Creatine malate

Creatine combined with malic acid, an intermediate in the citric acid cycle. The stated rationale attaches an additional energy-metabolism mechanism to the creatine. That is mechanistically plausible at the level of biochemistry textbook pathways and untested at the level of whether adding malate to creatine produces any advantage a person would notice. It also dilutes the creatine content per gram, so dose comparisons need care.

Creatine nitrate

Creatine paired with a nitrate group, borrowing the vasodilation narrative from dietary nitrate research. Two separate ideas are being fused here. Nitrate has its own literature; creatine has its own literature. Combining them in one salt does not transfer the evidence from either to the combination — that would require testing the combination itself. Solubility is again improved. Clinical superiority over monohydrate is unknown.

Who might reasonably use something other than monohydrate?

A narrow group, and for reasons unrelated to performance:

  • People who consistently experience gastrointestinal discomfort on monohydrate even after splitting the dose and taking it with food. Trying a more soluble form is a tolerability experiment, not a performance upgrade, and it should be framed that way.
  • People who genuinely cannot tolerate the texture of an incompletely dissolved powder. Micronised monohydrate — the same compound with a smaller particle size, and therefore the same evidence base — usually solves this without leaving the researched form.

Everyone else is paying more for less evidence. The other objection people raise about monohydrate — the first-week weight gain — is a separate question, and I unpack it in what creatine actually does to body water.

How should you rank the criteria when choosing?

In order of how well each criterion is actually supported, rather than how prominently it appears on packaging:

  1. Choose the form the trials used — monohydrate. Direct human outcome evidence. This is the only criterion on the list backed at the top of the evidence hierarchy.
  2. Check the creatine content per serving, not the total powder weight. Salts and complexes dilute the active molecule differently. Established chemistry.
  3. Prefer a supplier that documents purity and creatinine content. Biomarker-supported at best — it addresses a genuine manufacturing variable, but purity documentation is not itself an outcome.
  4. Solubility and particle size. Mechanistically plausible as a compliance and comfort factor; not demonstrated to change muscle loading.
  5. Proprietary buffering, esterification, or added acids. Untested against monohydrate in the comparison that would matter.

Verdict

There is no genuine head-to-head contest here, because the head-to-head trials that would decide it have largely not been done — and the burden of proof sits with the more expensive form, not the cheaper one. Monohydrate is the sensible default: it is the cheapest well-studied form, it is chemically the same active molecule as everything competing with it, and micronised versions solve most of its practical annoyances without stepping outside its evidence base.

Where an alternative form has real chemistry behind it — hydrochloride's solubility is the clearest case — that chemistry has not been shown to become a better result in a person. If any of these forms had demonstrated a meaningful advantage in a controlled comparison, the evidence would have changed practice by now. It has not.

Sources

This article argues largely from an absence of comparative human evidence. That absence is not our impression — it has been examined directly. A critical review by Kreider, Jäger and Purpura went through the marketed alternatives one by one and concluded that no purported form of creatine has been shown to be a more effective source of creatine than monohydrate, and that most were either less bioavailable, less effective, more expensive, or insufficiently studied for safety and efficacy. Their earlier 2011 analysis reached the same conclusion and, as the 2022 update notes, the marketing claims continued regardless.

Where a claim here rests on chemistry (solubility, hydrolysis, molar mass) it is stated as chemistry, not as an outcome. Where it rests on human data, that data was generated with monohydrate.

Popular articles


Content on this site is for informational and educational purposes only and is not medical advice. Consult a physician or pharmacist before starting any supplementation.

Contents